Pfizer Inc. Debt Securities Underwriting AgreementUnderwriting Agreement • August 18th, 2021 • Pfizer Inc • Pharmaceutical preparations • New York
From time to time Pfizer Inc., a Delaware corporation (the “Company”), proposes to enter into one or more Pricing Agreements (each a “Pricing Agreement”) in the form of Annex I hereto, with such additions and deletions as the parties thereto may determine, and subject to the terms and conditions stated herein and therein, to issue and sell to the firms named in Schedule I to the applicable Pricing Agreement (such firms constituting the “Underwriters” with respect to such Pricing Agreement and the securities specified therein) certain of its debt securities (the “Securities”) specified in Schedule II to such Pricing Agreement (with respect to such Pricing Agreement, the “Designated Securities”).
PRICING AGREEMENTPricing Agreement • August 18th, 2021 • Pfizer Inc • Pharmaceutical preparations
